Compass Pathways plc, a biotech company based in London, is developing a psilocybin-based therapy for CNS disorders. The company's shares declined by over 80% in 2022 due to safety concerns and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback